Program Agenda

1. Current Management of Follicular Non-Hodgkin’s Lymphoma (NHL)
2. Rationale for the Use of Radioimmunotherapy (RIT) in Follicular NHL
3. Characteristics, Clinical Pharmacology, and Rationale for Dosing Regimen of the BEXXAR^® Therapeutic Regimen
4. Patient-Specific Dosing of BEXXAR Using Dosimetry
5. Biodistribution Images
6. BEXXAR^® Clinical Studies
7. Safety of the BEXXAR^® Therapeutic Regimen
8. Radiation Safety and Outpatient Release Guidelines
9. Dose Preparation

Pending